S G Woolfrey

585 total citations
18 papers, 475 citations indexed

About

S G Woolfrey is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, S G Woolfrey has authored 18 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Oncology. Recurrent topics in S G Woolfrey's work include Cancer Treatment and Pharmacology (3 papers), Lanthanide and Transition Metal Complexes (2 papers) and Medical Imaging and Pathology Studies (2 papers). S G Woolfrey is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), Lanthanide and Transition Metal Complexes (2 papers) and Medical Imaging and Pathology Studies (2 papers). S G Woolfrey collaborates with scholars based in United Kingdom, United States and Sweden. S G Woolfrey's co-authors include I.W. Kellaway, Susan A. Farr, Michael J. Groves, James Gilmour Morrison, Peter C. White, Bryan E. Marshall, Dennis Greenslade, Martin A. Graham, Alexandra A. Smith and Glyn Taylor and has published in prestigious journals such as Journal of Colloid and Interface Science, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

S G Woolfrey

17 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S G Woolfrey United Kingdom 11 130 75 68 48 47 18 475
Milica Bajčetić Serbia 14 46 0.4× 105 1.4× 27 0.4× 26 0.5× 52 1.1× 50 564
Ruohan Li China 15 103 0.8× 119 1.6× 32 0.5× 48 1.0× 11 0.2× 51 730
Marc Galtier France 11 44 0.3× 92 1.2× 132 1.9× 40 0.8× 7 0.1× 19 470
Anil Vasudevan India 16 65 0.5× 92 1.2× 13 0.2× 109 2.3× 50 1.1× 44 683
Raghda R. S. Hussein Egypt 14 337 2.6× 65 0.9× 50 0.7× 51 1.1× 22 0.5× 52 607
Ziyan Shen China 15 55 0.4× 150 2.0× 29 0.4× 12 0.3× 47 1.0× 39 743
Mathieu Desmard France 16 108 0.8× 300 4.0× 17 0.3× 79 1.6× 45 1.0× 31 774
Xiaochuang Wang China 13 130 1.0× 170 2.3× 29 0.4× 17 0.4× 12 0.3× 44 713
Martin Šíma Czechia 12 58 0.4× 78 1.0× 44 0.6× 27 0.6× 7 0.1× 85 488
J. Honorato Spain 11 156 1.2× 87 1.2× 45 0.7× 15 0.3× 7 0.1× 29 532

Countries citing papers authored by S G Woolfrey

Since Specialization
Citations

This map shows the geographic impact of S G Woolfrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S G Woolfrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S G Woolfrey more than expected).

Fields of papers citing papers by S G Woolfrey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S G Woolfrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S G Woolfrey. The network helps show where S G Woolfrey may publish in the future.

Co-authorship network of co-authors of S G Woolfrey

This figure shows the co-authorship network connecting the top 25 collaborators of S G Woolfrey. A scholar is included among the top collaborators of S G Woolfrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S G Woolfrey. S G Woolfrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Marshall, Bryan E., et al.. (2015). Effects of fluoroquinolone restriction (from 2007 to 2012) on resistance in Enterobacteriaceae: interrupted time-series analysis. Journal of Hospital Infection. 91(1). 68–73. 37 indexed citations
2.
Sarma, Jayanta, et al.. (2015). Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis. Journal of Hospital Infection. 91(1). 74–80. 40 indexed citations
3.
Woolfrey, S G, et al.. (2006). PIII-67Effect of orlistat on the pharmacokinetic of rimonabant. Clinical Pharmacology & Therapeutics. 79(2). P77–P77. 2 indexed citations
4.
Morrison, James Gilmour, et al.. (2000). Validation of a highly sensitive ICP-MS method for the determination of platinum in biofluids: application to clinical pharmacokinetic studies with oxaliplatin. Journal of Pharmaceutical and Biomedical Analysis. 24(1). 1–10. 94 indexed citations
5.
Morrison, James Gilmour, et al.. (2000). Validation of an inductively coupled plasma (ICP) MS method as applied to measure oxaliplatin-derived platinum in pharmacokinetic studies. Chromatographia. 52(S1). S104–S104. 1 indexed citations
6.
Firth, James D., et al.. (1998). Biotransformation and pharmacokinetic analysis of oxaliplatin in patients with advanced gastrointestinal cancer. 39. 159. 13 indexed citations
7.
Fox, Peter, et al.. (1996). A Sensitive Assay for Cyclo-Phosphamide in Human Plasma Utilizing Mass Spectroscopy. Journal of Liquid Chromatography & Related Technologies. 19(7). 1047–1059. 3 indexed citations
8.
Woolfrey, S G, Hans Thysell, Peter Fox, et al.. (1995). Dose Regimen Adjustment for Milrinone in Congestive Heart Failure Patients with Moderate and Severe Renal Failure. Journal of Pharmacy and Pharmacology. 47(8). 651–655. 23 indexed citations
9.
SHERRY, K. M., et al.. (1994). Disposition of milrinone in patients after cardiac surgery. British Journal of Anaesthesia. 72(4). 426–429. 18 indexed citations
10.
Woolfrey, S G, et al.. (1993). Fluoxetine-warfarin interaction.. BMJ. 307(6898). 241.3–241. 35 indexed citations
11.
Woolfrey, S G, K.J. Palin, & S.S. Davis. (1989). The effect of Miglyol 812 oil on the oral absorption of propranolol in the rat. Journal of Pharmacy and Pharmacology. 41(8). 579–581. 4 indexed citations
12.
Woolfrey, S G, Glyn Taylor, I.W. Kellaway, & Alexandra A. Smith. (1987). Pulmonary absorption of liposome-encapsulated 6-carboxyfluorescein. Journal of Controlled Release. 5(3). 203–209. 20 indexed citations
13.
Woolfrey, S G, Glyn Taylor, I.W. Kellaway, & Alexandra A. Smith. (1986). The Uptake of Liposome-Encapsulated Carboxyfluorescein from the Rat Lung. Journal of Pharmacy and Pharmacology. 38(Supplement_12). 34P–34P. 1 indexed citations
14.
Woolfrey, S G, Glyn Taylor, I.W. Kellaway, & Alexandra A. Smith. (1986). Pulmonary absorption of carboxyfluorescein in the rat. Journal of Pharmacy and Pharmacology. 38(4). 304–306. 11 indexed citations
15.
Woolfrey, S G, et al.. (1986). The effect of sodium chloride on the dynamic surface tension of sodium dodecyl sulfate solutions. Journal of Colloid and Interface Science. 112(2). 583–587. 64 indexed citations
16.
Woolfrey, S G, Glyn Taylor, I.W. Kellaway, & Alexandra A. Smith. (1985). Disposition of carboxyfluorescein in the rat. International Journal of Pharmaceutics. 26(1-2). 35–43. 10 indexed citations
17.
Farr, Susan A., et al.. (1985). 99m-Technetium as a marker of liposomal deposition and clearance in the human lung. International Journal of Pharmaceutics. 26(3). 303–316. 99 indexed citations
18.
Farr, Stephen J., et al.. (1985). Short Term Fate of Pulmonary Delivered Technetium-99m Labelled Liposomes. Journal of Pharmacy and Pharmacology. 37(Supplement_12). 61P–61P.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Milica Bajčetić Breakdown of academic impact, for papers by Ruohan Li Breakdown of academic impact, for papers by Marc Galtier Breakdown of academic impact, for papers by Anil Vasudevan Breakdown of academic impact, for papers by Raghda R. S. Hussein Breakdown of academic impact, for papers by Ziyan Shen Breakdown of academic impact, for papers by Mathieu Desmard Breakdown of academic impact, for papers by Xiaochuang Wang Breakdown of academic impact, for papers by Martin Šíma Breakdown of academic impact, for papers by J. Honorato
Rankless by CCL
2026